Nanotechnology needs for cardiovascular sciences

Pascal Goldschmidt-Clermont, David J. Kandzari, Samer Khouri, Mauro Ferrari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In medicine, the cardiovascular field is the most technically advanced discipline. The inherent technical challenges associated with the beating heart and the structure of the cardiovascular system has forced us to innovate from a biomedical engineering standpoint. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for our patients. In spite of such progress, cardiovascular disease remains the major cause of death, morbidity, and disability in the United States [1-3]. To eradicate heart disease within the next fifty years, substantial advances will be needed, and in particular, important technological hurdles need to be overcome. We foresee the progress in the field of nanotechnology could represent a major breakthrough in addressing some of our technical challenges. With this essay, we provide a glimpse at potentially important targets for nanotechnology in the field of cardiovascular medicine. By no means will this review attempt to be comprehensive but instead, it has been designed to trigger the interest of discoverers with substantial knowledge in the field of very small things.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalBiomedical Microdevices
Volume3
Issue number2
DOIs
StatePublished - Aug 15 2001
Externally publishedYes

Fingerprint

Nanotechnology
Medicine
Biomedical Engineering
Cardiovascular system
Biomedical engineering
Cardiovascular System
Cause of Death
Heart Diseases
Cardiovascular Diseases
Technology
Morbidity
Therapeutics

Keywords

  • Cardiovascular disease
  • Cardiovascular imaging
  • Cellular transplant
  • Local drug delivery
  • Nanogenomics
  • Nanotechnology
  • Smart stent

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Genetics
  • Neuroscience(all)

Cite this

Goldschmidt-Clermont, P., Kandzari, D. J., Khouri, S., & Ferrari, M. (2001). Nanotechnology needs for cardiovascular sciences. Biomedical Microdevices, 3(2), 83-88. https://doi.org/10.1023/A:1011485823750

Nanotechnology needs for cardiovascular sciences. / Goldschmidt-Clermont, Pascal; Kandzari, David J.; Khouri, Samer; Ferrari, Mauro.

In: Biomedical Microdevices, Vol. 3, No. 2, 15.08.2001, p. 83-88.

Research output: Contribution to journalArticle

Goldschmidt-Clermont, P, Kandzari, DJ, Khouri, S & Ferrari, M 2001, 'Nanotechnology needs for cardiovascular sciences', Biomedical Microdevices, vol. 3, no. 2, pp. 83-88. https://doi.org/10.1023/A:1011485823750
Goldschmidt-Clermont P, Kandzari DJ, Khouri S, Ferrari M. Nanotechnology needs for cardiovascular sciences. Biomedical Microdevices. 2001 Aug 15;3(2):83-88. https://doi.org/10.1023/A:1011485823750
Goldschmidt-Clermont, Pascal ; Kandzari, David J. ; Khouri, Samer ; Ferrari, Mauro. / Nanotechnology needs for cardiovascular sciences. In: Biomedical Microdevices. 2001 ; Vol. 3, No. 2. pp. 83-88.
@article{f15123ed6fb1471e9e334cee39919ebe,
title = "Nanotechnology needs for cardiovascular sciences",
abstract = "In medicine, the cardiovascular field is the most technically advanced discipline. The inherent technical challenges associated with the beating heart and the structure of the cardiovascular system has forced us to innovate from a biomedical engineering standpoint. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for our patients. In spite of such progress, cardiovascular disease remains the major cause of death, morbidity, and disability in the United States [1-3]. To eradicate heart disease within the next fifty years, substantial advances will be needed, and in particular, important technological hurdles need to be overcome. We foresee the progress in the field of nanotechnology could represent a major breakthrough in addressing some of our technical challenges. With this essay, we provide a glimpse at potentially important targets for nanotechnology in the field of cardiovascular medicine. By no means will this review attempt to be comprehensive but instead, it has been designed to trigger the interest of discoverers with substantial knowledge in the field of very small things.",
keywords = "Cardiovascular disease, Cardiovascular imaging, Cellular transplant, Local drug delivery, Nanogenomics, Nanotechnology, Smart stent",
author = "Pascal Goldschmidt-Clermont and Kandzari, {David J.} and Samer Khouri and Mauro Ferrari",
year = "2001",
month = "8",
day = "15",
doi = "10.1023/A:1011485823750",
language = "English",
volume = "3",
pages = "83--88",
journal = "Biomedical Microdevices",
issn = "1387-2176",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Nanotechnology needs for cardiovascular sciences

AU - Goldschmidt-Clermont, Pascal

AU - Kandzari, David J.

AU - Khouri, Samer

AU - Ferrari, Mauro

PY - 2001/8/15

Y1 - 2001/8/15

N2 - In medicine, the cardiovascular field is the most technically advanced discipline. The inherent technical challenges associated with the beating heart and the structure of the cardiovascular system has forced us to innovate from a biomedical engineering standpoint. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for our patients. In spite of such progress, cardiovascular disease remains the major cause of death, morbidity, and disability in the United States [1-3]. To eradicate heart disease within the next fifty years, substantial advances will be needed, and in particular, important technological hurdles need to be overcome. We foresee the progress in the field of nanotechnology could represent a major breakthrough in addressing some of our technical challenges. With this essay, we provide a glimpse at potentially important targets for nanotechnology in the field of cardiovascular medicine. By no means will this review attempt to be comprehensive but instead, it has been designed to trigger the interest of discoverers with substantial knowledge in the field of very small things.

AB - In medicine, the cardiovascular field is the most technically advanced discipline. The inherent technical challenges associated with the beating heart and the structure of the cardiovascular system has forced us to innovate from a biomedical engineering standpoint. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for our patients. In spite of such progress, cardiovascular disease remains the major cause of death, morbidity, and disability in the United States [1-3]. To eradicate heart disease within the next fifty years, substantial advances will be needed, and in particular, important technological hurdles need to be overcome. We foresee the progress in the field of nanotechnology could represent a major breakthrough in addressing some of our technical challenges. With this essay, we provide a glimpse at potentially important targets for nanotechnology in the field of cardiovascular medicine. By no means will this review attempt to be comprehensive but instead, it has been designed to trigger the interest of discoverers with substantial knowledge in the field of very small things.

KW - Cardiovascular disease

KW - Cardiovascular imaging

KW - Cellular transplant

KW - Local drug delivery

KW - Nanogenomics

KW - Nanotechnology

KW - Smart stent

UR - http://www.scopus.com/inward/record.url?scp=0034904727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034904727&partnerID=8YFLogxK

U2 - 10.1023/A:1011485823750

DO - 10.1023/A:1011485823750

M3 - Article

VL - 3

SP - 83

EP - 88

JO - Biomedical Microdevices

JF - Biomedical Microdevices

SN - 1387-2176

IS - 2

ER -